4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CYCS Gene (Entity type)	0.008964079
4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	SLPI Gene (Entity type)	-0.01058587
4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	PHLDA1 Gene (Entity type)	0.008448442
4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	ELANE Gene (Entity type)	-0.010517118
4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	BMP2 Gene (Entity type)	-0.009560156
4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	DKK1 Gene (Entity type)	0.012852287
dantron Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine Compound (Entity type)	0.2687133848667145
4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	PT-630 Compound (Entity type)	0.3326205313205719
4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	CXCL8 Gene (Entity type)	-0.013856368
4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	PODXL Gene (Entity type)	0.008560164

4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CYCS
Gene (Entity type)
0.008964079

4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
SLPI
Gene (Entity type)
-0.01058587

4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
PHLDA1
Gene (Entity type)
0.008448442

4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
ELANE
Gene (Entity type)
-0.010517118

4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
BMP2
Gene (Entity type)
-0.009560156

4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
DKK1
Gene (Entity type)
0.012852287

dantron
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine
Compound (Entity type)
0.2687133848667145

4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
PT-630
Compound (Entity type)
0.3326205313205719

4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
CXCL8
Gene (Entity type)
-0.013856368

4-[3-(3H-Imidazol-4-yl)-propyl]-piperidine
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
PODXL
Gene (Entity type)
0.008560164

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.